Data from public SEC Form 4 filings. For information only, not investment advice. Created by Caleb Love.
6 insiders of Rapport Therapeutics, Inc. bought shares on the open market between 2026-10-21 and 2026-10-23, $1.66M in total (61,694 shares at an average of $26.99). Buyers include 1 officer(s), 5 director(s). The largest single buyer, PAUL STEVEN M (Director), accounts for 58.5% of the dollar value.
| Insider | Role | Bought |
|---|---|---|
| PAUL STEVEN M | Director | $974K |
| MARAGANORE JOHN | Director | $249K |
| Ignelzi Troy A. | Chief Financial Officer | $144K |
| Young Wendy B. | Director | $100K |
| Silva Paul M | Director | $100K |
| Sanchez Ramiro | Director | $98K |
Latest filing: SEC EDGAR · all Form 4s for CIK 0002012593
https://sec-edgar-api.kidriahx.workers.dev/mcp.Data: U.S. SEC EDGAR Form 4 filings (public domain), open-market non-derivative purchases (code P) only, parsed automatically by MonRiah Studio. Pages are generated by software from those filings; summaries are computed from the numbers, not written by a person. Not affiliated with the SEC. Not investment advice; insider buying is one data point, filings can be amended, and parsing can be wrong; always check the linked filing.